Jack Gorsline

​Jack is a Boston-based investigative reporter covering the psychedelic and cannabis legalization movements in New England and nationwide. His reporting has also been published by the Boston Institute for Nonprofit Journalism (BINJ), by Talking Joints Memo and on his substack, Psychedelic State(s) of America.

Why a Psychedelics Campaign in Washington State Stands Out

What comes next for the "psychedelic renaissance"? Massachusetts has a decriminalization and limited legalization measure on the November ballot. Comparable…

October 15, 2024

DEA Bids to Exclude Expert Witnesses From Psychedelics-Ban Hearing

The Drug Enforcement Administration is seeking to exclude what advocates say is key testimony from an upcoming hearing on the…

October 4, 2024

Psychedelic Advocates Air FDA Frustrations at Reagan-Udall Meeting

On September 6, the Reagan-Udall Foundation for the Food and Drug Administration, an independent nonprofit created by Congress in 2007…

September 9, 2024

DEA Schedules Historic Public Hearing on Psychedelics DOI, DOC

The Drug Enforcement Administration’s years-long campaign to ban two lesser-known psychedelic substances—2,5-Dimethoxy-4-iodoamphetamine (DOI) and 2,5-Dimethoxy-4-chloroamphetamine (DOC)—has faced consistent opposition from…

August 27, 2024

Cambridge, MA, Endorses Statewide Psychedelic Ballot Measure

Supporters of a Massachusetts psychedelic decriminalization and legalization measure scored a big win on the night of August 5, as…

August 7, 2024

Student Group in Renewed Bid to Block DEA Psychedelics Ban

On July 23, Students for Sensible Drug Policy (SSDP) representatives filed a prehearing statement to the Drug Enforcement Administration’s Office…

July 25, 2024